Abstract

Sabia virus Glycoprotein G1 (GP1) is a peripheral membrane protein involved in viral adsorption and consequential pathogenic infection. Glycoprotein G1 (GP1) was subjected to immunoformatic and molecular simulation study to predict effective B-cell and T-cell epitopes with knowledge-based exploration of probable immunological responses the epitopes may elicit. The linear and conformational epitopes of GP1 for B-cell were predicted by immunoformatic tools housed in IEDB recourse. Both CD4+ and CD8+ T-cell epitopes were predicted exploiting IEDB recourse tools whereas CD8+ T cell epitopes were severed further by immune response evoking ability of epitope-MHC complex. Contribution of GP1 to innate antiviral response was evolved by interferon (IFN)-gamma inducing and imitation capacity by immunoformatic and docking study respectively. The results of the B-cell epitope analysis suggest the occurrence of potential linear and conformational epitope with cross-reactivity. A range of T-cell epitopes were assumed to be involved in MHC class I and MHC class II molecule dependent antigen presentation. Glycoprotein G1 (GP1) may induce the IFNgamma but its IFN-gamma mimicking ability (confirmed by docking study) that adduces a prompt immune defense. Therefore, inherent immunological repertoire of GP1 epitopes can be taken in to advantage in future immunization regiment development against Sabia virus.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call